robert henric
posted a blog.
According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) – Global Forecast”, published by MarketsandMarkets™, is expected to reach USD 724.5 million, nearly at a CAGR of 21.7% during the forecast period.
The growth is primarily driven by factors such as the growth in the pharmaceutical and biotechnology industries, increasing number of new drug launches, R&D investments in life science, advancements in nano-filtration technology, and high incidence and large economic burden of chronic diseases.
Objectives of the Study;
To define, measure, and describe the global viral clearance market by application, method, end user, and region
To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197
Geographically; the North American region is expected to account for the largest share of the market in 2018. The viral clearance market in the region is driven by the presence of national institutes supporting biotechnology and life science research, growth in the pharmaceuticals industry, and the increasing number of drug approvals.
However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.
The key players in the global viral clearance market are Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).
Merck KGaA (Germany) is one of the leading players in the viral clearance market. The company’s Process Solutions business unit offers over 15,000 products and services including single-use manufacturing, filtration, chromatography, purification, virus reduction, drug delivery compounds, and engineering and validation services. R&D is a key area of focus for Merck-it invested USD 272.3 million in R&D activities in 2017. The company strives to expand its product portfolio, build a better network for increasing its customer base, and enter new markets. The company mainly focuses on achieving organic growth to expand its geographic presence in international markets.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197
The recombinant proteins segment is expected to account for the largest share.
On the basis of application, is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications. In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules. Furthermore, the regulatory requirement to demonstrate the capacity of the purification process to effectively clear infectious viruses during the manufacturing of recombinant proteins is also expected to support the growth of this market segment during the forecast period.
The pharmaceutical & biotechnology companies segment is expected to account for the largest share.
By end user, the viral clearance market is segmented into pharmaceutical & biotechnology companies, CROs, academic research institutes, and other end users. In 2018, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the global market. The large share of this segment can be attributed to the rapid expansion of the biopharmaceutical industry, growth in the number of research activities in life sciences, increasing R&D investments in drug development, and increasing number of drug launches.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=62681197
Be the first person to like this.
robert henric
posted a blog.
According to the new market research report “Electronic Trial Master File Systems Market by Component (Services, Software), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Delivery Mode (On-Premise, Cloud-Based), and Region – Global Forecast to 2024″, published by MarketsandMarkets™, the eTMF systems market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%
Electronic Trial Master File (eTMF) Systems Market Size Estimation;
Both top-down and bottom-up approaches were used to estimate and validate the total size of the eTMF systems market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
– The key players in the industry and markets have been identified through extensive secondary research
– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94357456
North America dominated the Electronic Trial Master File Systems Market in 2018; this trend to continue during the forecast period
Geographically, the eTMF Systems Market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The North American market accounted for the largest share of the Electronic Trial Master File (eTMF) Systems Market in 2018, primarily due to the increasing government funding for clinical research and a large number of clinical trials. Several major global players are also based in the US, owing to which the country has become a center of innovation in the Electronic Trial Master File Systems Market.
Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl (US), SureClinical, Inc. (US), Dell EMC (US), Paragon Solutions (US), PharmaVigilant (US), Mayo Clinic (US), Database Integrations, Inc. (US), CareLex (US), Ennov (France), Forte Research (US), Freyr (US), Montrium (US), NCGS Inc. (US), SAFE-BioPharma (US), SterlingBio Inc. (US), BIOVIA Corp. (US), and arivis AG (Germany) are the key players in the Electronic Trial Master File Systems Market
Veeva Systems was the leading player in the electronic trial master file (eTMF) systems market in 2018. The company’s dominant position can be attributed to its solution, Veeva Vault eTMF. The company focuses on various inorganic and organic growth strategies such as solution deployments and expansions to maintain and enhance its market share. In the last three years, Veeva Systems has deployed its solutions at more than ten pharmaceutical companies, CROs, and other sites in the US to expand its user base with the development of innovative solutions. The company also has a strategic focus on expansions in growing emerging markets, such as the Middle East and Asia.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94357456
The cloud-based eTMF to register the highest CAGR during the forecast period
Based on delivery mode, the eTMF Systems Market is segmented into on-premise and cloud-based eTMF. The cloud-based eTMF segment is expected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the comparatively lower capital expenses & operational costs incurred in this model, alongside its scalability, flexibility, and affordability.
Cloud-based solutions help healthcare organizations share and integrate information from different locations, making the process of data gathering seamless. Moreover, these solutions are comparatively affordable to install and maintain as compared to on-premise solutions, thus contributing to the high growth and popularity of the cloud-based delivery model.
The heavy dependence of end-users on service providers will drive the services segment in the eTMF systems market
Based on the component, the Electronic Trial Master File Systems Market is segmented into services and software. The services segment accounted for the largest market share in 2018. The large share of this segment can be attributed to their indispensable nature and repetitive requirement. End-users of eTMF systems rely heavily on service providers for consulting, data storage, implementing services, training, maintenance, and regular upgrades of solutions.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94357456
Be the first person to like this.
robert henric
posted a blog.
According to the new market research report “Medical Cameras Market by Camera Type (Endoscopy Cameras, Ophthalmology Cameras, Dermatology Cameras), Resolution (HD Cameras, SD Cameras), Sensor (CMOS, CCD), End-Users (Hospitals & Ambulatory Surgery Centers, Specialty Clinics) – Global Forecast to 2026″, published by MarketsandMarkets™, is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.3% during the forecast period.
Growth Driver: The increasing number of surgical procedures
An increasing number of surgical procedures require medical cameras, which has considerably grown in recent years. The growing number of surgeries can be attributed to the rapidly growing geriatric population worldwide and the increasing prevalence of chronic diseases, leading to the increasing demand for medical equipment. Many countries across the world are facing the challenge of increasing senior populations. According to the United Nations (UN), in 2019, there were 703 million persons aged 65 years or over in the world. The senior population is estimated to double to 1.5 billion in 2050. Non-invasive surgeries (mainly using endoscopy and microscopy surgery cameras) are preferred for older people due to lesser complications than conventional surgeries.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201071746
North America dominates the global medical cameras market
Geograpgically, segmented into five regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America dominated the global market. The large share of the North American region is mainly attributed to the technological advancements in medical cameras, implementation of favorable government initiatives, and rise in the number of surgical procedures.
The major players in the medical cameras market are Olympus Corporation (Japan), Richard WOLF GmbH (Germany), TOPCON CORPORATION (Japan), Sony Corporation (Japan), Stryker Corporation (US), Danaher Corporation (US), Canon Inc. (Japan), Carl Zeiss AG (Germany), Smith & Nephew (UK), Carestream Dental LLC (US), and Basler AG (Germany)
Olympus Corporation is one of the leading providers of medical cameras. The company has established itself as one of the leading players in the medical cameras market with a wide distribution network worldwide. The company offers camera heads widely used across various specialties, including general surgery, ENT, urology, and OR integration. The company has a geographical presence in more than 39 countries with the help of its subsidiaries and distributor network. Additionally, the company has more than 20,000 patents across its product portfolio.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=201071746
The CMOS Sensor segment accounted for the largest market share in 2020.
Based on sensor, the medical cameras market is segmented into CMOS Sensor and CCD Sensor. CMOS Sensors accounted for the largest share of the global market in 2020. This can be attributed various advantages of CMOS sensors over CCD sensors, such as low power consumption, ease of integration, and faster frame rate. Moreover, the cost of manufacturing these sensors is lower than that of CCD sensors.
The High-definition cameras accounted for largest market share in 2020
Based on resolution, segmented into standard-definition (SD) cameras and high-definition (HD) cameras. High-definition cameras accounted for the largest share of the global market in 2020. The large share of this segment can primarily be attributed to the greater demand for HD cameras among end users due to the significant requirement of high-quality images in medical specialties.
Hospitals & ambulatory surgery centers are the largest end-users of the medical cameras market
Based on end users, segmented into hospitals & ambulatory surgery centers and specialty clinics. Hospitals & ambulatory surgery centers accounted for the largest share of the global medical camera market in 2020. This can be attributed to the increasing number of hospitals, especially in India, China, and Africa, and growing government & private investments to upgrade healthcare infrastructures.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=201071746
Be the first person to like this.
robert henric
posted a blog.
According to the new market research report “Protein Crystallization and Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region – Global Forecast to 2025″, published by MarketsandMarkets™, the Protein Crystallization Market is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.
Recent Developments:
In 2020, Calibre Scientific (US) acquired NeXtal Biotechnologies (Product Line of QIAGEN) (Netherlands) to strengthen its portfolio of structural biology solutions.
In 2019, Charles River Laboratories (US) collaborated with CHDI Foundation (US) for the drug discovery and development of therapies for Huntington’s disease.
In 2018, Bruker Corporation launched a new product, D8 DISCOVER Plus X-ray Diffraction (XRD).
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=147057058
North America dominates the Protein Crystallization and Crystallography Market.
The protein crystallization market is divided into five major regions, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the global market, followed by Europe. The growth in this market can be attributed to the increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, and the rising demand for high-quality research tools.
The Americas and Europe are the established markets for protein crystallization & crystallography. The developing regions, including BRIC (Brazil, Russia, India, and China) countries, are expected to form the new revenue pockets for this market. A rise in the spending power of these countries is the major driver for the growth of crystallization of protein. With the advent of new technologies like cryo-crystallization, improved radiation sources, and more sensitive detectors, the protein crystallization and crystallography market will see a robust growth in the near future. The increasing and immediate need for high-resolution information on protein structures, increasing government funding, and increasing R&D in the pharmaceutical and biotechnological arenas are also factors driving the growth of the protein crystallization market. However, lack of qualified and experienced researchers and the highly time-consuming and expensive protein crystallization & crystallography process restricts the growth of the market to some extent.
The major companies in the Protein Crystallography Market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=147057058
The consumables segment accounted for the largest market share in 2019.
On the basis of product and service, the consumables segment accounted for the largest share of the Protein Crystallization Market in 2019. This can be attributed to a large number of reagent kits and microplates used in proteomics research and the increasing demand for miniature screening plates in automated liquid handlers.
The pharmaceutical companies segment accounted for the largest market share in 2019.
The pharmaceutical companies segment accounted for the largest share of the Protein Crystallography Market in 2019. This can be attributed to the increasing demand for protein-based drugs and the increasing demand for biologics in various application areas
Be the first person to like this.
robert henric
posted a blog.
According to the new market research report “Rehabilitation Equipment Market by Product (Mobility, Cane, Crutches, Walker, Body Support, Lift, Beds, Sling, Exercise, Therapy, Reading, Writing), Application (Physical, OT, Strength) End User (Physiotherapy, Hospital, Clinic) – Global Forecast to 2025″, published by MarketsandMarkets™, the Rehab Equipment Market is projected to reach USD 16.6 billion by 2025 from USD 12.9 billion in 2020, at a CAGR of 5.2%.
Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the global rehabilitation equipment market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
The key players in the industry and markets have been identified through extensive secondary research.
The revenue generated from the sale of rehabilitation equipment by leading players has been determined through primary and secondary research.
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194775519
Europe dominates the global Rehabilitation Equipment Market.
Based on region, segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, Europe accounted for the largest market share. Factors such as supportive government initiatives for safe patient handling, rising geriatric population, and the high burden of chronic conditions are driving the growth of the European market.
The Rehabilitation Equipment Market the presence of several big and small players. Some of the prominent players offering rehabilitation equipment include Invacare Corporation (US), Medline Industries, Inc. (US), Hill-Rom Services Inc. (US), Dynatronics Corporation (US), Drive DeVilbiss Healthcare (US), DJO Global, Inc. (US), Carex Health Brands, Inc. (US), Roma Medical (UK). These players adopted various growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to further expand their presence in the global Rehab Equipment Market.
Hill-Rom Holdings provides a wide range of rehabilitation equipment such as patient lifts, medical beds, and accessories. The company majorly focuses on R&D investments for the continuous development and upgradation of its products. In 2018, the company invested USD 0.14 billion in R&D activities. The company’s constant focus on innovation helps it in enhancing its product offerings and marking its presence in the rehabilitation equipment market.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=194775519
Therapy equipment segment is projected to grow at the highest CAGR during the forecast period.
Based on product, the Rehabilitation Equipment Market is segmented into therapy equipment, daily living aids, mobility equipment, exercise equipment, and body support devices. The therapy equipment segment is projected to register the highest growth rate during the forecast period. The growth of this segment is primarily attributed to the increasing incidence of various injuries and chronic conditions.
The home care settings segment is projected to grow at the highest CAGR during the forecast period.
Based on end user, the Rehab Equipment Market is segmented into hospitals and clinics, rehabilitation centers, physiotherapy centers, home care settings, and other end users. The home care settings segment is projected to grow at the highest CAGR during the forecast period. The growth of this end-user segment can be attributed to the increasing focus on reducing healthcare costs and government initiatives to promote home healthcare. In addition, healthcare spending for home services has grown significantly, reflecting an increase in the use of home-based services.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=194775519
Be the first person to like this.